Skip to main content
. 2019 Apr 9;10:745. doi: 10.3389/fimmu.2019.00745

Table 3.

Clinical and demographic features of sIBM patients.

Gender Age CK Anti-NT5c1A titer
(MFU)*
Dysphagia (Y/N) Severity
(1 = Mild, 2 = Moderate, 3 = Severe)
F 54 732 276 Y 2
M 83 812 576 Y 2
F 82 163 1457 Y 3
M 79 170 3815 Y 1
M 79 533 3042 Y 2
F 76 792 400 Y 3
M 75 419 6034 Y 3
M 75 219 869 Y 2
F 73 486 803 Y 2
F 73 250 23911 Y 2
M 71 153 387 Y 1.5
F 71 175 1312 Y 2.5
M 70 490 278 Y 2
F 70 N/A 246 Y 1
F 69 476 1594 Y 1.5
M 67 669 740 Y 2.5
M 65 329 1683 Y 2
F 62 796 336 Y 2
M 60 N/A 592 Y 3
F 57 1265 26623 Y 2
M 56 363 17748 Y 2.5
F 56 710 1903 Y 3
M 54 261 112 Y 1
M 86 355 151 N 2
M 81 110 331 N 2
M 76 703 441 N 1
M 76 279 184 N 1
F 75 232 157 N 1.5
M 74 391 99.5 N 2
F 74 901 12370 N 1
F 73 215 649.5 N 1.5
M 72 305 518 N 1.5
M 72 502 12706 N 2
M 69 469 256 N 2
M 67 624 283 N 2
M 67 500 164 N 1.5
F 67 310 157 N 2
M 60 N/A 477 N 2
M 58 481 4960 N 2
M 55 367 1039 N 2
M 54 596 276 N 1.5
F 54 617 1023 N 3
M 53 204 21563 N 3
37.2% female Median: 70.0
IQR 60.0,75.0
Median: 444.0
IQR 252.8, 622.3
Median: 592.0
IQR 276.0, 1903.0
53% had dysphagia Median: 2.0
IQR 1.5, 2.1
*

Shaded cells indicate positive results of >600 MFU (cutoff). F, female; IQR, interquartile range; M, male; MFU, median fluorescence units; NA, not available; N, no; Y, yes.